pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS clinical programs — 30 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
BEONE MEDICINES AUS projects
30 ClinicalTrials.gov programs sponsored by BEONE MEDICINES AUS.
BEONE MEDICINES AUS has 30 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BGB-11417 for Previously Untreated Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS PTY LTD
Previously Untreated Chronic Lymphocytic Leukemia
1 trial -
BGB-11417-302
BEONE MEDICINES AUS PTY LTD
relapsed or refractory mantle cell lymphoma (R/R MCL)
1 trial -
BGB-11417-303CLL-RR1
BEONE MEDICINES AUS PTY LTD
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
BGB-11417-304
BEONE MEDICINES AUS PTY LTD
treatment-naive Chronic Lymphocytic Leukemia
1 trial -
BGB-16673
BEONE MEDICINES AUS PTY LTD
CLL
1 trial -
BGB-16673
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia
2 trials -
BGB-16673-302
BEONE MEDICINES AUS PTY LTD
Chronic lymphotic leukemia and Small Lymphocytic lymphoma
1 trial -
BGB-16673-304
BEONE MEDICINES AUS PTY LTD
Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)
1 trial -
BGB-3111-304
BEONE MEDICINES AUS PTY LTD
Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
1 trial -
BGB-3111-306
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma
1 trial -
BGB-43395
BEONE MEDICINES AUS PTY LTD
HR+/HER2- Breast Cancer
1 trial -
BGB-A317-290-LTE1
BEONE MEDICINES AUS PTY LTD
Solid tumors and hamatological malignancies
1 trial -
BGB-A317-316
BEONE MEDICINES AUS PTY LTD
Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
1 trial -
Pamiparib capsule
BEONE MEDICINES AUS PTY LTD
Ovarian Cancer
1 trial -
Sonrotoclax
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia
4 trials -
Sonrotoclax
BEONE MEDICINES AUS PTY LTD
CLL
1 trial -
Sonrotoclax
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma
1 trial -
Subcutaneous Tislelizumab
BEONE MEDICINES AUS PTY LTD
Metastatic Gastric Adenocarcinoma
1 trial -
Tislelizumab
BEONE MEDICINES AUS PTY LTD
Advanced Malignancies
1 trial -
Tislelizumab
BEONE MEDICINES AUS PTY LTD
Classical Hodgkin Lymphoma
1 trial -
Tislelizumab
BEONE MEDICINES AUS PTY LTD
Urothelial Carcinoma
1 trial -
Tislelizumab
BEONE MEDICINES AUS PTY LTD
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
Tislelizumab
BEONE MEDICINES AUS PTY LTD
Non Small Cell Lung Cancer
4 trials -
Zanidatamab
BEONE MEDICINES AUS PTY LTD
Gastric Neoplasms
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Primary Membranous Nephropathy
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
B-cell Malignancies
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia
2 trials -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Relapsed/Refractory Follicular Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
B-cell malignancies
1 trial -
zanubrutinib
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
1 trial
Frequently asked questions
How many clinical projects does BEONE MEDICINES AUS have?
30 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.